Costs of vaccine programs across 94 low- and middle-income countries

Vaccine

Volumn 33, Issue S1, 2015, Pages A99-A108

  Portnoy, Allison ^a   Ozawa, Sachiko ^a   Grewal, Simrun ^a   Norman, Bryan A ^b   Rajgopal, Jayant ^b   Gorham, Katrin M ^a   Haidari, Leila A ^a,c   Brown, Shawn T ^c   Lee, Bruce Y ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b University of Pittsburgh   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Costs; Routine immunization; Supplemental immunization activities; Supply chain; Vaccine

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; JAPANESE ENCEPHALITIS VACCINE; MALARIA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES RUBELLA VACCINE; MEASLES VACCINE; MENINGITIS VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; TYPHOID VACCINE; VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ARTICLE; BENIN; DIPHTHERIA; DRUG COST; DRUG STORAGE; ENERGY COST; ETHIOPIA; HEALTH CARE DELIVERY; HEPATITIS B; HUMAN; IMMUNIZATION; INDIA; JAPANESE ENCEPHALITIS; LOWEST INCOME GROUP; MALARIA; MEASLES; MENINGITIS; MONTE CARLO METHOD; MOZAMBIQUE; MUMPS; NIGER; NIGERIA; PAKISTAN; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESOURCE ALLOCATION; ROTAVIRUS INFECTION; RUBELLA; SHIPPING; SIMULATION; STATISTICAL SIGNIFICANCE; TETANUS; TRAFFIC AND TRANSPORT; TUBERCULOSIS; TYPHOID FEVER; VACCINATION; YELLOW FEVER; DEVELOPING COUNTRY; ECONOMICS; HEALTH; INFANT; NEWBORN; ORGANIZATION AND MANAGEMENT; SUPPLY AND DISTRIBUTION;

DEVELOPING COUNTRIES; GLOBAL HEALTH; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; VACCINATION; VACCINES;

EID: 84928599851     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.037     Document Type: Article

References (45)

1. World Health Organization Meeting of the Strategic Advisory Group of Experts on Immunization, February 2012-Report from the Extraordinary SAGE Meeting on Decade of Vaccines 2012, Available at: http://www.who.int/immunization/sage_conclusions/en/index1.html.
2. World Health Organization Global vaccine action plan 2011-2020 2013, World Health Organization, Geneva, Available at: http://www.dovcollaboration.org/action-plan/.
3. GAVI Alliance GAVI Alliance co-financing policy 2012, GAVI Alliance, Geneva.
4. GAVI Alliance Adjusted demand forecast version 9.0 2014, GAVI Alliance, Geneva, (Released 2 April 2014).
5. World Health Organization Global measles and rubella strategic plan 2012-2020 2012, World Health Organization, Geneva, Available at: http://www.who.int/immunization/newsroom/Measles_Rubella_StrategicPlan_2012_2020.pdf.
6. Global Polio Eradication Initiative (GPEI) Financial resource requirements 2013-2018 2013, WHO/UNICEF, Geneva.
7. GAVI Alliance Vaccine introduction grants and operational support for campaigns policy 2012, GAVI Alliance, Geneva.
8. GAVI Alliance GAVI vaccine price forecasts 2013, GAVI Alliance, Geneva, (Provided for the DOVE Analysis 20 September 2013).
9. GAVI Alliance Country ceilings and 5-year budget breakdown for country applications submitted in 2013 2013, GAVI Alliance, Geneva.
10. GAVI Alliance All countries commitments and disbursements 2014, GAVI Alliance, Geneva.
11. GAVI Alliance Country ceilings and maximum annual amounts for budgeting for GAVI Health Systems Strengthening (HSS) grant applications submitted in 2014 2014, GAVI Alliance, Geneva.
12. PAHO Revolving Fund Expanded program of immunization vaccine prices for year 2011 2011, PAHO Revolving Fund, Washington, DC, Available at: http://www.paho.org/hq/.
13. PAHO Revolving Fund Expanded program of immunization vaccine prices for year 2012 2012, PAHO Revolving Fund, Washington, DC, Available at: http://www.paho.org/hq/.
14. PAHO Revolving Fund Expanded program of immunization vaccine prices for year 2013 2013, PAHO Revolving Fund, Washington, DC, Available at: http://www.paho.org/hq/.
15. PAHO Revolving Fund Expanded program of immunization vaccine prices for year 2014 2014, PAHO Revolving Fund, Washington, DC, Available at: http://www.paho.org/hq/.
16. UNICEF. UNICEF supplies & logistics: vaccine price data 2013, UNICEF Supplies and Logistics, New York, NY, May 31. 2013 ed.
17. Brown S.T., Schreiber B., Cakouros B.E., Wateska A.R., Dicko H.M., et al. The benefits of redesigning Benin's vaccine supply chain. Vaccine 2014, 32(32):4097-4103.
18. Lee B.Y., Cakouros B.E., Assi T.M., Connor D.L., Welling J., et al. The impact of making vaccines thermostable in Niger's vaccine supply chain. Vaccine 2012, 30(38):5637-5643.
19. International Monetary Fund (IMF) World Economic Outlook (WEO) database 2013, IMF, Washington, DC.
20. United Nations Department of Economic Social Affairs PD World population prospects: the 2012 revision 2012, UN Population Division, New York, NY.
21. WHO/UNICEF. Estimates of national immunization coverage 2013, WHO/UNICEF, Geneva.
22. The World Bank World development indicators 2014, The World Bank, Washington, DC, (Last updated: 09-Apr-).
23. WHO/UNICEF WHO-UNICEF guidelines for developing a comprehensive multi-year plan WHO/IVB/0520 2006, WHO, Geneva.
24. Gandhi G., Lydon P., Cornejo S., Brenzel L., Wrobel S., et al. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020. Vaccine 2013, 31(Suppl. 2B):137-148.
25. Gandhi G., Lydon P. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts. BMC Public Health 2014, 14(67).
26. Lydon P, Gandhi G, Vandelaer J, Okwo-Bele JM. Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade? Bulletin of the World Health Organization 2014;92(5):382-384.
27. Agnandji S.T., Lell B., Fernandes J.F., Abossolo B.P., Methogo B.G., et al. A phase 3 trial of RTS S/AS01 malaria vaccine in African infants. N Engl J Med 2012, 367(24):2284-2295.
28. PATH Public-sector preferences for RTS S/AS01 malaria vaccine formulation, presentation, and packaging 2008, PATH, (Online). Available from: http://www.technet21.org/index.php/documents/view-document/715-public-sector-preferences-for-rtss/as01-malaria-vaccine-formulation-presentation-and-packaging.html (Accessed 25 October 2013).
29. Hutton G., Tediosi F. The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania. Am J Trop Med Hyg 2006, 75(2 Suppl.):119-130.
30. Maire N., Shillcutt S.D., Walker D.G., Tediosi F., Smith T.A. Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria. Value Health 2011, 14(8):1028-1038.
31. Assi T.M., Brown S.T., Djibo A., Norman B.A., Rajgopal J., et al. Impact of changing the measles vaccine vial size on Niger's vaccine supply cha a computational model. BMC Public Health 2011, 1142:5.
32. Assi T.M., Brown S.T., Kone S., Norman B.A., Djibo A., et al. Removing the regional level from the Niger vaccine supply chain. Vaccine 2013, 31(26):2828-2834.
33. Assi T.M., Rookkapan K., Rajgopal J., Sornsrivichai V., Brown S.T., et al. How influenza vaccination policy may affect vaccine logistics. Vaccine 2012, 30(30):4517-4523.
34. Brown S.T., Lee B.Y. Unless changes are made in Benin, multiple storage and transport bottlenecks may prevent vaccines from reaching the population. Vaccine 2014, 32(21):2518-2519.
35. Lee B.Y., Assi T.M., Rookkapan K., Wateska A.R., Rajgopal J., et al. Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand. PLoS One 2011, 6(9):e24673.
36. Lee B.Y., Norman B.A., Assi T.M., Chen S.I., Bailey R.R., et al. Single versus multi-dose vaccine vials: an economic computational model. Vaccine 2010, 28(32):5292-5300.
37. Haidari L.A., Connor D.L., Wateska A.R., Brown S.T., Mueller L.E., et al. Augmenting transport versus increasing cold storage to improve vaccine supply chains. PLoS One 2013, 8(5):e64303.
38. Lee B.Y., Assi T.M., Rajgopal J., Norman B.A., Chen S.I., et al. Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger. Am J Public Health 2012, 102(2):269-276.
39. Haidari L.A., Connor D.L., Wateska A.R., Brown S.T., Mueller L.E., et al. Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks. J Public Health Manag Pract 2013, 19(Suppl. 2):S65-S67.
40. GAVI Alliance Joint GPEI-GAVI statement on the availability and price of inactivated polio vaccine 2014, GAVI Alliance, Geneva, Available at: http://www.gavialliance.org/Library/News/Statements/2014/Joint-GPEI-GAVI-statement-on-the-Availability-and-Price-of-Inactivated-Polio-Vaccine/.
41. GAVI Alliance Adjusted demand forecast version 4.0 2011, GAVI Alliance, Geneva.
42. Sarley D., Allain L., Akkihal A. Estimating the global in-country supply chain costs of meeting the mdgs by 2015 2009.
43. Yadav P., Tata H., Babaley M. Storage and supply chain management: the world medicines situation report 2011, World Health Organization, Geneva, Available at: http://www.who.int/medicines/areas/policy/world_medicines_situation/en/.
44. Brenzel L., Wolfson L.J., Fox-Rushby J., Miller M., Halsey N.A. Vaccine-preventable diseases. Disease control priorities in developing countries 2006, The International Bank for Reconstruction and Development/The World Bank Group, Washington DC. D.T. Jamison, J.G. Breman, A.R. Measham, G. Alleyne, M. Claeson (Eds.).
45. Darmstadt G.L., Walker N., Lawn J.E., Bhutta Z.A., Haws R.A., et al. Saving newborn lives in Asia and Africa: cost and impact of phased scale-up of interventions within the continuum of care. Health Policy Plan 2008, 23(2):101-117.